Shen KY - Search Results

1

A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection.

Tzeng TT, Chai KM, Shen KY, Yu CY, Yang SJ, Huang WC, Liao HC, Chiu FF, Dou HY, Liao CL, Chen HW, Liu SJ. Tzeng TT, et al. Among authors: shen ky. NPJ Vaccines. 2022 Jun 3;7(1):60. doi: 10.1038/s41541-022-00482-0. NPJ Vaccines. 2022. PMID: 35662254 Free PMC article.

2

Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo.

Song YC, Chou AH, Homhuan A, Huang MH, Chiang SK, Shen KY, Chuang PW, Leng CH, Tao MH, Chong P, Liu SJ. Song YC, et al. Among authors: shen ky. J Leukoc Biol. 2011 Aug;90(2):323-32. doi: 10.1189/jlb.0111046. Epub 2011 Apr 26. J Leukoc Biol. 2011. PMID: 21521754

3

Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.

Huang CY, Chen JJ, Shen KY, Chang LS, Yeh YC, Chen IH, Chong P, Liu SJ, Leng CH. Huang CY, et al. Among authors: shen ky. PLoS One. 2012;7(7):e40970. doi: 10.1371/journal.pone.0040970. Epub 2012 Jul 18. PLoS One. 2012. PMID: 22815882 Free PMC article.

4

Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.

Shen KY, Song YC, Chen IH, Leng CH, Chen HW, Li HJ, Chong P, Liu SJ. Shen KY, et al. J Immunol. 2014 May 1;192(9):4233-41. doi: 10.4049/jimmunol.1302850. Epub 2014 Mar 28. J Immunol. 2014. PMID: 24683188 Free PMC article.

5

Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.

Shen KY, Chang LS, Leng CH, Liu SJ. Shen KY, et al. Expert Rev Vaccines. 2015 Mar;14(3):383-94. doi: 10.1586/14760584.2015.966696. Epub 2014 Dec 2. Expert Rev Vaccines. 2015. PMID: 25455657 Free article. Review.

6

Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide.

Shen KY, Song YC, Chen IH, Chong P, Liu SJ. Shen KY, et al. Hum Vaccin Immunother. 2014;10(11):3241-50. doi: 10.4161/hv.29275. Hum Vaccin Immunother. 2014. PMID: 25483652 Free PMC article.

7

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.

Wu CC, Liu SJ, Chen HW, Shen KY, Leng CH. Wu CC, et al. Among authors: shen ky. Oncotarget. 2016 May 24;7(21):30804-19. doi: 10.18632/oncotarget.9001. Oncotarget. 2016. PMID: 27127171 Free PMC article.

8

A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.

Shen KY, Liu HY, Li HJ, Wu CC, Liou GG, Chang YC, Leng CH, Liu SJ. Shen KY, et al. J Control Release. 2016 Jul 10;233:57-63. doi: 10.1016/j.jconrel.2016.05.008. Epub 2016 May 6. J Control Release. 2016. PMID: 27164542

9

Recent progress in GM-CSF-based cancer immunotherapy.

Yan WL, Shen KY, Tien CY, Chen YA, Liu SJ. Yan WL, et al. Among authors: shen ky. Immunotherapy. 2017 Mar;9(4):347-360. doi: 10.2217/imt-2016-0141. Immunotherapy. 2017. PMID: 28303764 Review.

10

Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy.

Lin MH, Shen KY, Liu BS, Chen IH, Sher YP, Tseng GC, Liu SJ, Sung WC. Lin MH, et al. Among authors: shen ky. Vaccine X. 2019 Mar 11;1:100017. doi: 10.1016/j.jvacx.2019.100017. eCollection 2019 Apr 11. Vaccine X. 2019. PMID: 31384738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters